Glycomic analysis
Our team, with years of experience in glycomics and proteomics technology, provides reliable analysis and will work in partnership to accelerate your research.
Chemily Glycoscience is developing into a major supplier for carbohydrate-based biochemicals, reagents and pharmaceuticals, and has been manufacturing several categories of products using it’s proprietary chemo-enzymatic and in vivo bioengineering technology. Some of the new developments include:
Based on its proprietary carbohydrate and uncommon sugar library (deposits), Chemily Glycoscience has been developing sugar-containing small molecules in therapeutic treatment options in two core disease areas: cancer and cardiovascular diseases. Recently, Chemily has also been licensing and developing novel glycoconjugation technology to produce polysaccharide-protein conjugate vaccines and therapeutic glycoproteins at unprecedented cost-effective levels.
Click here to add your own text